Multiple Sclerosis News Today Forums › Forums › Treating MS › MS Medications › #ECTRIMS2019 – Ocrevus Living Up to Expectations, Says Hideki Garren of Genentech

  • MS Medications

    #ECTRIMS2019 – Ocrevus Living Up to Expectations, Says Hideki Garren of Genentech

    Posted by MS News Today Moderator on September 27, 2019 at 10:03 am

    Two years after its approval and with new data from ECTRIMS, Ocrevus is living up to its designation as a “game-changer,” Genentech’s Hideki Garren says. Read more here.

    Do you agree that Ocrevus is a “game-changer” for people with MS?

    replied 5 years, 9 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .